Clinical Trials Browser

Phase 1/2 × Unknown × avelumab × Clear all

NCT03787602 2023-03-02

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

Phase 1/2 Unknown

Carcinoma, Merkel Cell

NCT02630368 2022-02-02

METROmaJX

Phase 1/2 Unknown

Breast Neoplasms, Sarcoma

NCT02767063 2020-08-07

ACTIW

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT03844763 2020-03-03

CONFRONT

Phase 1/2 Unknown

Head and Neck Neoplasms